Tag: Vaccines
11.1 Anaphylaxis Cases/Million Doses of Pfizer-BioNTech COVID-19 Vaccine Reported
Median interval from vaccine receipt to symptom onset was 13 minutes
U.K. Is First Country to Approve Oxford-AstraZeneca COVID-19 Vaccine
Vaccine could become the dominant form of inoculation because at $3 to $4 a dose, it is a fraction of the cost of other vaccines
HD Live! Takes a Look Back at Pandemic’s Progression
David Shulkin, M.D., and Joel Zivot, M.D., discuss handling of pandemic, overcoming vaccine hesitancy
Majority Do Not Support COVID-19 Vaccine Mandates for Adults
Employer mandates deemed more acceptable than state mandates
FDA Issues EUA for Moderna COVID-19 Vaccine
On Sunday, ACIP voted to recommend frontline workers and those ages 75 years and older be included in next phase of vaccine distribution
Low U.S. Flu Rates Seen as Pandemic Rages
Many more people are getting flu shots to avoid the risk for getting both the flu and COVID-19
Advisory Committee Votes to Recommend EUA for Moderna Vaccine
Could become the second COVID-19 vaccine in a week to receive emergency use authorization
Pfizer-BioNTech Vaccine Receives Emergency Use Authorization
CDC director says vaccine distribution could begin as early as today
70 Percent Efficacy Found for Oxford COVID-19 Vaccine
Acceptable safety profile identified, with three serious adverse events classified as possibly related to the vaccine
FDA Advisory Committee OKs Pfizer-BioNTech COVID-19 Vaccine
Committee recommends emergency use authorization of the vaccine; vaccine to be distributed within 24 hours of EUA
